SCHEMBL30946430

SCHEMBL30946430

Nc1ccc(C(F)(F)F)c(-n2nccn2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.50
▸ TSHR P16473 2/20 0.50
▸ GLA P06280 1/20 0.50
▸ POLB P06746 1/20 0.50
▸ MAPT P10636 4/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ TP53 P04637 1/20 0.43
▸ KIF11 P52732 3/20 0.40
▸ NR1H2 P55055 1/20 0.38
▸ NTRK1 P04629 1/20 0.37
▸ SYK P43405 1/20 0.36
▸ ALDH1A1 P00352 3/20 0.35
▸ KDM4E B2RXH2 3/20 0.35
▸ AR P10275 2/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ CASP1 P29466 2/20 0.35
▸ SRC P12931 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ CASP7 P55210 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14320657 1.00 GAA (0.50) GAATSHRGLAPOLBMAPT
SCHEMBL30517118 0.87 GAA (0.52) GAATSHRGLAPOLBMAPT
SCHEMBL19817407 0.87 GAA (0.52) GAATSHRGLAPOLBMAPT
SCHEMBL30946489 0.79 MAPT (0.41) GAATSHRGLAPOLBMAPT
SCHEMBL31284854 0.79 GAA (0.40) GAATSHRGLAPOLBMAPT
SCHEMBL31284048 0.79 TSHR (0.40) GAATSHRGLAPOLBMAPT
SCHEMBL30946497 0.79 HCAR1 (0.37) MAPTNTRK1SYKALDH1A1MEN1
SCHEMBL2627231 0.76 NPC1 (0.36) GAATSHRGLAPOLBMAPT
SCHEMBL827884 0.74 TSHR (0.70) GAATSHRGLAPOLBMAPT
SCHEMBL29420085 0.74 TSHR (0.70) GAATSHRGLAPOLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4743085-A2 COMPOUNDS, COMPOSITIONS, AND METHODS Tenvie Therapeutics, Inc. (US) 2026-05-20 — — EP disclosed
EP-4634161-A2 COMPOUNDS, COMPOSITIONS, AND METHODS Tenvie Therapeutics Inc. (US) 2025-10-22 — — EP disclosed
WO-2025019357-A2 COMPOUNDS, COMPOSITIONS, AND METHODS NICO THERAPEUTICS, INC. (US) 2025-01-23 — — WO disclosed
WO-2024130166-A2 COMPOUNDS, COMPOSITIONS, AND METHODS DENALI THERAPEUTICS INC. (US) 2024-06-20 — — WO disclosed
Send feedback